CombiMatrix Receives Delisting Warning from Nasdaq

In a letter to the company, Nasdaq said that the firm is not in compliance with requirements that its stock equity be at least $10 million to remain trading on the Nasdaq Global Market.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories